Motivational Interviewing in the Control of Arterial Hypertension and Type 2 Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

April 11, 2018

Primary Completion Date

June 20, 2019

Study Completion Date

March 12, 2021

Conditions
Type 2 Diabetes MellitusSystemic Arterial Hypertension
Interventions
BEHAVIORAL

Motivational interviewing

In Diabetes and hypertension, nursing consultations to support the care should be focused on their educational component the orientation of measures that prove to reduce blood pressure, improve the glycemic indices, the lipid profile and the Cardiovascular risk classification, among them: adherence to drug therapy, proper diet, body weight maintenance, stimulating active life and regular physical exercise, reducing alcoholic beverage consumption, reducing stress and abandoning Smoking. In this group, these care will be addressed based on the principles and techniques of the Motivational Interviewing.

BEHAVIORAL

Nursing Consultation

In Diabetes and hypertension, nursing consultations to support the care should be focused on their educational component the orientation of measures that prove to reduce blood pressure, improve the glycemic indices, the lipid profile and the Cardiovascular risk classification, among them: adherence to drug therapy, proper diet, body weight maintenance, stimulating active life and regular physical exercise, reducing alcoholic beverage consumption, reducing stress and abandoning Smoking. In this group, these care will be approached in a conventional manner, as routine of the services, based on the recommendations of the Primary Care Strategy Notebooks for the care of chronic conditions in DM2 and SAH and the SSC-GHC Institutional Protocol for SAH and DM2 Patient Care.

Trial Locations (1)

91350-200

Nossa Senhora da Conceição Hospital, Porto Alegre

All Listed Sponsors
lead

Hospital Nossa Senhora da Conceicao

OTHER

NCT03729323 - Motivational Interviewing in the Control of Arterial Hypertension and Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter